HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AKESO

85.900

-2.100-2.39%

Volume:17.01M

Turnover:1.46B

Market Cap:77.14B

PE:-133.34

High:89.900

Open:86.150

Low:83.300

Close:88.000

Loading ...

Overview Company News Filings

Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings

Akeso Swings to Loss in 2024

MT Newswires Live

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape With Bispecific Antibodies

THOMSON REUTERS

Press Release: Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Akeso's Penpulimab Receives Nmpa Approval for First-Line Treatment of Nasopharyngeal Cancer

THOMSON REUTERS

Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up

Simply Wall St.

Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet

THOMSON REUTERS

Akeso Announces Completion of Patient Enrollment in the Phase Iii Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

THOMSON REUTERS

Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy

THOMSON REUTERS

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination With Pfizer's Adcs

THOMSON REUTERS

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Akeso Announces Ind Acceptance for Ak139, a Bispecific Antibody Targeting Il-4RΑ and St2 for Respiratory and Skin Diseases

THOMSON REUTERS

Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in Nsclc

THOMSON REUTERS

The Drug Industry Is Having Its Own DeepSeek Moment -- Heard on the Street -- WSJ

Akeso Announces the Completion of Patient Enrollment in the Phase Iii Clinical Trial (Harmoni-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-Nsclc

THOMSON REUTERS

Akeso's Gumokimab Monoclonal Antibody (Il-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by Nmpa

THOMSON REUTERS

Akeso Received Payment for the Development Collaboration on Tagitanlimab

THOMSON REUTERS

China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk

GF Securities Starts Akeso at Buy with HK$81.59 Price Target

MT Newswires Live

Akeso's Cervical Cancer Drug Included in China's National Reimbursement Drug List

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09926/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"AKESO","latestPrice":85.9,"timestamp":1743667696036,"preClose":88,"halted":0,"volume":17005351,"delay":0,"floatShares":898000000,"shares":898000000,"eps":-0.6442154841977593,"marketStatus":"Market Closed","change":-2.1,"latestTime":"04-03 16:08:16","open":86.15,"high":89.9,"low":83.3,"amount":1456077117,"amplitude":0.075,"askPrice":85.9,"askSize":10000,"bidPrice":85.85,"bidSize":39000,"shortable":3,"etf":0,"ttmEps":-0.6442154841977593,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":88,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.885599396978292,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":898000000,"roa":"-4.16%","roe":"-8.89%","lyrEps":-0.644215,"volumeRatio":0.885599396978292,"shares":898000000,"dividePrice":0,"high":89.9,"amplitude":0.075,"preClose":88,"low":83.3,"week52Low":26.45,"pbRate":"10.62","psRate":"34.08","week52High":89.9,"institutionHeld":0,"latestPrice":85.9,"committee":0.591837,"eps":-0.6442154841977593,"divideRate":0,"volume":17005351,"delay":0,"ttmEps":-0.6442154841977593,"open":86.15,"prevYearClose":60.7,"prevWeekClose":74.6,"prevMonthClose":76.2,"prevQuarterClose":76.2,"fiveDayClose":70.95,"twentyDayClose":71.9,"sixtyDayClose":59.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148796507","title":"Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1148796507","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148796507?lang=en_us&edition=fundamental","pubTime":"2025-04-01 13:03","pubTimestamp":1743483824,"startTime":"0","endTime":"0","summary":"Chinese biotechnology stocks rallied on Tuesday, driven by better-than-expected earnings from key players and investors seeking defensive sectors ahead of the looming US tariffs.Shares of $Akeso Inc.(","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-04-01/chinese-biotech-stocks-advance-on-better-earnings-more-deals","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["02359","03759","09926","03347","06606","02269"],"gpt_icon":1},{"id":"2523164917","title":"Akeso Swings to Loss in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2523164917","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523164917?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:07","pubTimestamp":1743419274,"startTime":"0","endTime":"0","summary":"Akeso  swung to an attributable loss of 514.5 million yuan in 2024 from a profit of 2.03 billion yuan in 2023, according to a Sunday filing with the Hong Kong bourse.The biopharmaceuticals producer swung to a loss per share of 0.60 yuan from earnings per share of 2.42 yuan in the previous year.Revenue declined 53% to 2.12 billion yuan from 4.53 billion yuan a year earlier.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1720050803.USD","BK1574","LU0348784397.USD","LU2488822045.USD","09926","LU1794554557.SGD","IE00BPRC5H50.USD","LU0417516571.SGD","IE00B543WZ88.USD","LU0348783233.USD","IE00B5MMRT66.SGD","BK1161"],"gpt_icon":0},{"id":"2523021988","title":"Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape With Bispecific Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2523021988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523021988?lang=en_us&edition=fundamental","pubTime":"2025-03-31 02:32","pubTimestamp":1743359543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250330:nTUA8WGGKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720050803.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1161","BK1574","LU0348783233.USD","LU0348784397.USD","09926","IE00BPRC5H50.USD","LU2488822045.USD","LU0417516571.SGD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2523988027","title":"Press Release: Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2523988027","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523988027?lang=en_us&edition=fundamental","pubTime":"2025-03-31 02:32","pubTimestamp":1743359520,"startTime":"0","endTime":"0","summary":"Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies. -- Global first \"immuno + anti-vascular\" bispecific antibody approved:. ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study. -- ivonescimab outperforms pembrolizumab in Phase III study for first-line. PD-L1+ NSCLC: mPFS HR=0.51; sNDA under priority review.-- Cadonilimab approved for first-line gastric cancer: Fills immunotherapy. gap for patients with low or negative PD-L1 expression.-- New commercial milestones: cadonilimab and ivonescimab added to the. -- AK117  enters Phase III trials: ivonescimab combined with AK117 for. On the commercial front, Akeso's adjustments in drug pricing and optimization of its commercial systems led to new drug sales revenue surpassing RMB 2 billion in 2024, a 25% year-on-year increase. The company continues to reduce operating losses, with an EBITDA loss of 225 million RMB in 2024.\"We are thrilled to have reac","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","BK1161","LU1794554557.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU0348783233.USD","BK1574","BK4585","LU0348784397.USD","LU1720050803.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK4107","BK4588","09926","LU0053666078.USD","L"],"gpt_icon":0},{"id":"2520285554","title":"Akeso's Penpulimab Receives Nmpa Approval for First-Line Treatment of Nasopharyngeal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520285554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520285554?lang=en_us&edition=fundamental","pubTime":"2025-03-17 11:49","pubTimestamp":1742183395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA23GYV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1794554557.SGD","LU0348784397.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","09926","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD","IE00B5MMRT66.SGD","BK1574","LU0417516571.SGD","BK1161"],"gpt_icon":0},{"id":"2519320395","title":"Akeso, Inc.'s (HKG:9926) Shares Climb 28% But Its Business Is Yet to Catch Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2519320395","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519320395?lang=en_us&edition=fundamental","pubTime":"2025-03-16 08:35","pubTimestamp":1742085344,"startTime":"0","endTime":"0","summary":"Akeso, Inc. ( HKG:9926 ) shareholders would be excited to see that the share price has had a great month, posting a 28...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-incs-hkg9926-shares-climb-28-but-its-business-is-yet-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B5MMRT66.SGD","BK1161","09926","IE00BPRC5H50.USD","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD","LU0417516571.SGD","BK1574","LU1794554557.SGD","IE00B543WZ88.USD","LU0348784397.USD"],"gpt_icon":0},{"id":"2517129678","title":"Akeso Announces the Publication of Its Phase Iii Clinical Trial Results for Ivonescimab in Head-to-Head Comparison With Pembrolizumab in the Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=2517129678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517129678?lang=en_us&edition=fundamental","pubTime":"2025-03-07 13:04","pubTimestamp":1741323844,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nTUA5CG3YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09926","LU0348784397.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK1161","BK1574","LU1794554557.SGD","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD"],"gpt_icon":0},{"id":"2517979311","title":"Akeso Announces Completion of Patient Enrollment in the Phase Iii Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517979311?lang=en_us&edition=fundamental","pubTime":"2025-03-06 08:30","pubTimestamp":1741221002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nTUA48VPCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09926","LU1720050803.USD","BK1161","IE00B543WZ88.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348783233.USD","BK1574","LU0417516571.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2514270658","title":"Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for \"IO 2.0 + ADC\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2514270658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514270658?lang=en_us&edition=fundamental","pubTime":"2025-02-27 16:58","pubTimestamp":1740646720,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nTUA82CJGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","LU0348784397.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","IE00B543WZ88.USD","BK1161","LU2488822045.USD","LU0417516571.SGD","LU0348783233.USD","09926","IE00BPRC5H50.USD","LU1720050803.USD"],"gpt_icon":0},{"id":"2514086204","title":"Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination With Pfizer's Adcs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086204","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514086204?lang=en_us&edition=fundamental","pubTime":"2025-02-25 09:14","pubTimestamp":1740446043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8P9HQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BPRC5H50.USD","LU2488822045.USD","BK1574","LU0348784397.USD","IE00B543WZ88.USD","09926","LU0348783233.USD","LU0417516571.SGD","LU1794554557.SGD","IE00B5MMRT66.SGD","LU1720050803.USD","BK1161"],"gpt_icon":0},{"id":"2513408847","title":"Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos","url":"https://stock-news.laohu8.com/highlight/detail?id=2513408847","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513408847?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:44","pubTimestamp":1740397440,"startTime":"0","endTime":"0","summary":"Summit Therapeutics and Pfizer will work together to study Summit's promising cancer drug candidate ivonescimab and Pfizer's antibody drug conjugates, or ADCs, in solid tumors.Summit on Monday said the companies plan to evaluate ivonescimab in combination with several Pfizer ADCs across multiple solid tumor settings to determine the safety profile and potential anti-tumor activity of the combinations.Miami biopharmaceutical company Summit said it will provide ivonescimab for use in the proposed studies, slated to begin in the middle of the year, with New York drugmaker Pfizer being responsible for conducting the studies.Summit has licensed the rights to ivonescimab in North and South America, Europe, the Middle East, Africa and Japan from Chinese biotech Akeso, which engineered the drug.Summit last year reported data from a late-stage study that showed ivonescimab beat Merck's blockbuster cancer drug Keytruda in patients with a form of lung cancer.Pfizer is developing several ADCs, whi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1069347547.HKD","SG9999002224.SGD","LU0321505868.SGD","BK4581","LU1794554557.SGD","LU1974910355.USD","09926","SMMT","MRK","LU0965509283.SGD","IE00B2B36J28.USD","LU1066051811.HKD","ADC","LENZ","BK4007","IE0002270589.USD","SG9999001176.USD","SG9999013999.USD","LU0965508806.USD","LU0985481810.HKD","BK4559","LU0306807586.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","SG9999014542.SGD","BK4568","BK4592","LU1989772923.USD","IE00BN8TJ469.HKD","LU0234572021.USD","LU1023059063.AUD","BK4533","PFE","LU1035773651.USD","LU1066051225.USD","BK4516","LU0203347892.USD","SG9999015358.SGD","BK1161","BK1574","LU1989772840.SGD","LU0265550359.USD","LU1571399168.USD","LU0320765489.SGD","LU2324357040.USD","LU1941712264.USD","LU2461242641.AUD","SMMF","LU0348784397.USD","LU0965509101.SGD"],"gpt_icon":0},{"id":"2511500401","title":"Akeso Announces Ind Acceptance for Ak139, a Bispecific Antibody Targeting Il-4RΑ and St2 for Respiratory and Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2511500401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511500401?lang=en_us&edition=fundamental","pubTime":"2025-02-14 09:11","pubTimestamp":1739495509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nTUA36QPBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09926","LU1720050803.USD","BK1161","IE00B543WZ88.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","LU0348783233.USD","BK1574","LU0417516571.SGD","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2511557255","title":"Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2511557255","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511557255?lang=en_us&edition=fundamental","pubTime":"2025-02-13 09:26","pubTimestamp":1739410007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA7LRSQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09926","LU0348784397.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","BK1161","BK1574","LU1794554557.SGD","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD"],"gpt_icon":0},{"id":"2509715922","title":"The Drug Industry Is Having Its Own DeepSeek Moment -- Heard on the Street -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2509715922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509715922?lang=en_us&edition=fundamental","pubTime":"2025-02-07 18:30","pubTimestamp":1738924200,"startTime":"0","endTime":"0","summary":"The biotech industry's DeepSeek moment came last fall.That is when Summit Therapeutics, backed by billionaire  Bob Duggan, announced that its drug had outperformed Merck's blockbuster therapy Keytruda in a head-to-head lung-cancer trial. Keytruda, a $30 billion-a-year immunotherapy juggernaut, is the bestselling drug in the pharma industry and has long dominated the market. So the prospect of a superior competitor was seismic. Even more remarkable: Summit had licensed the drug just two years earlier from a little known Chinese biotech called Akeso.But Chinese innovation is steadily improving and is already starting to disrupt the U.S. drug-development ecosystem. For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by talent streaming from top academic centers like Massachusetts Institute of Technology and Stanford University. Those biotech companies have an insatiable client in Big Pharma, which is willing to pay top","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","AZN","VKTX","NVO","SMMT","09926","03692"],"gpt_icon":1},{"id":"2509267819","title":"Akeso Announces the Completion of Patient Enrollment in the Phase Iii Clinical Trial (Harmoni-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2509267819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509267819?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:28","pubTimestamp":1738805292,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA27ZLZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BPRC5H50.USD","LU0348783233.USD","IE00B5MMRT66.SGD","LU1720050803.USD","BK1574","LU2488822045.USD","LU1794554557.SGD","LU0417516571.SGD","IE00B543WZ88.USD","09926","BK1161","LU0348784397.USD"],"gpt_icon":0},{"id":"2506313247","title":"Akeso's Gumokimab Monoclonal Antibody (Il-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2506313247","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506313247?lang=en_us&edition=fundamental","pubTime":"2025-01-27 09:53","pubTimestamp":1737942796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nTUA6HXKQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B543WZ88.USD","LU0417516571.SGD","LU0348784397.USD","LU1720050803.USD","BK1161","IE00BPRC5H50.USD","LU0348783233.USD","LU1794554557.SGD","09926","BK1574","LU2488822045.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2505876006","title":"Akeso Received Payment for the Development Collaboration on Tagitanlimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2505876006","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505876006?lang=en_us&edition=fundamental","pubTime":"2025-01-22 14:57","pubTimestamp":1737529053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nTUA9QGTJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720050803.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","IE00B543WZ88.USD","09926","LU2488822045.USD","BK1161","LU0348784397.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2501292221","title":"China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2501292221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501292221?lang=en_us&edition=fundamental","pubTime":"2025-01-07 16:23","pubTimestamp":1736238180,"startTime":"0","endTime":"0","summary":"0822 GMT - China's healthcare sector will likely get a significant boost from national policies in 1Q, Citi analysts write in a note. This year marks the start of the most positive structural change in the industry, as it will be the first time that China's public healthcare system is able to include commercial insurance providers as significant payers, they say. The brokerage recommends buying shares in companies that will be direct beneficiaries of the reform. These include pharmaceutical and biopharmaceutical firms, pharmaceutical distributors and medical device companies. Citi's top picks include Jiangsu Hengrui Medicine, Hansoh Pharmaceutical, SSY Group, Akeso, Sichuan Kelun-Biotech Biopharmaceutical, Mindray Medical, Sinopharm Group, WuXi AppTec, Wuxi Biologics and Gushengtang. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245094.SGD","02273","06990","BK0012","LU0326950275.SGD","LU0588546209.SGD","LU1064131003.USD","LU0359201612.USD","LU2460026573.USD","SHTDY","LU0856984785.SGD","603259","LU0516423174.USD","BK0188","LU1880383366.USD","03692","LU0348735423.USD","LU0052750758.USD","LU0405327148.USD","BK1191","BK1583","BK1589","LU0359202008.SGD","LU0516422952.EUR","BK4137","LU0819121731.USD","LU0456846285.SGD","LU0140636845.USD","09926","02269","BK1576","LU0348784397.USD","01099","BK1219","600276","LU0196878994.USD","LU0039217434.USD","LU0348825331.USD","BK0196","LU0516422440.USD","LU0640798160.USD","LU0979878070.USD","LU1242518857.USD","BK1574","02005","IE00B543WZ88.USD","LU1328615791.USD","BK1610","HCSG","LU0516422366.SGD"],"gpt_icon":0},{"id":"2490988722","title":"GF Securities Starts Akeso at Buy with HK$81.59 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2490988722","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490988722?lang=en_us&edition=fundamental","pubTime":"2024-12-11 16:12","pubTimestamp":1733904722,"startTime":"0","endTime":"0","summary":"GF Securities Starts Akeso at Buy with HK$81.59 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GF","09926"],"gpt_icon":0},{"id":"2486398470","title":"Akeso's Cervical Cancer Drug Included in China's National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=2486398470","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486398470?lang=en_us&edition=fundamental","pubTime":"2024-11-28 17:29","pubTimestamp":1732786141,"startTime":"0","endTime":"0","summary":"Akeso's  cadonilimab has been included in the updated National Reimbursement Drug List released by China's National Healthcare Security Administration for the first time, a Thursday bourse filing by the drug firm said.Cadonilimab has been included in the list for the treatment of recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapy.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B543WZ88.USD","LU1720050803.USD","09926","BK1161","IE00BPRC5H50.USD","LU2488822045.USD","LU0348783233.USD","LU0348784397.USD","LU0417516571.SGD","BK1574","LU1794554557.SGD","IE00B5MMRT66.SGD","NHLD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"Post Market","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-18","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710725400000,"name":null,"time":"","dateTimestamp":1710691200000,"actualEps":null},{"date":"2023-08-29","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"market":"HK","date":"2023-04-27","symbol":"09926","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682524800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.35,"buy":0.6,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":20,"updateTime":1743609600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2025-04-03","current":-139.968555,"percent":0.001663,"low":-143.429114,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"high":20.221708,"avg":-24.799868,"sd":29.115838,"marketCap":77100161418},"quantilePoints":[{"date":"2020-04-24","current":-50.518886,"twenty":-43.769381,"median":-33.645124,"eighty":-33.597989,"marketCap":18544136176},{"date":"2020-04-29","current":-54.430966,"twenty":-54.873187,"median":-52.474926,"eighty":-33.645124,"marketCap":19994089211},{"date":"2020-05-08","current":-50.146246,"twenty":-54.430966,"median":-50.765107,"eighty":-50.046102,"marketCap":18429666200},{"date":"2020-05-15","current":-53.0553,"twenty":-54.153595,"median":-51.221035,"eighty":-50.046102,"marketCap":19421739329},{"date":"2020-05-22","current":-55.542078,"twenty":-56.818854,"median":-53.301351,"eighty":-50.146246,"marketCap":20266722282},{"date":"2020-05-29","current":-55.414226,"twenty":-57.202877,"median":-54.292281,"eighty":-50.518886,"marketCap":20188016564},{"date":"2020-06-05","current":-58.444689,"twenty":-58.967855,"median":-55.265323,"eighty":-50.732575,"marketCap":21447308046},{"date":"2020-06-12","current":-63.276404,"twenty":-59.542646,"median":-55.820181,"eighty":-50.765107,"marketCap":23218186692},{"date":"2020-06-19","current":-68.299799,"twenty":-60.537832,"median":-56.858534,"eighty":-51.676962,"marketCap":25107123914},{"date":"2020-06-26","current":-80.148198,"twenty":-63.334108,"median":-58.348972,"eighty":-52.779632,"marketCap":29435938382},{"date":"2020-07-03","current":-77.885169,"twenty":-66.643902,"median":-58.880358,"eighty":-53.202931,"marketCap":28648881206},{"date":"2020-07-10","current":-76.725563,"twenty":-70.305822,"median":-59.096072,"eighty":-53.649064,"marketCap":28491469771},{"date":"2020-07-17","current":-70.467076,"twenty":-73.692098,"median":-59.898011,"eighty":-54.044506,"marketCap":26209003960},{"date":"2020-07-24","current":-65.539086,"twenty":-72.620808,"median":-60.537717,"eighty":-54.320018,"marketCap":24280713879},{"date":"2020-07-31","current":-65.051015,"twenty":-71.63744,"median":-61.425183,"eighty":-54.696299,"marketCap":24241361020},{"date":"2020-08-07","current":-61.60528,"twenty":-71.199223,"median":-62.665648,"eighty":-55.108469,"marketCap":22982069539},{"date":"2020-08-14","current":-60.398898,"twenty":-70.692859,"median":-61.425183,"eighty":-55.354665,"marketCap":22588540951},{"date":"2020-08-21","current":-65.573062,"twenty":-70.162934,"median":-62.07047,"eighty":-55.490937,"marketCap":24634889608},{"date":"2020-08-28","current":-62.258841,"twenty":-69.624858,"median":-61.507641,"eighty":-55.875802,"marketCap":23572362421},{"date":"2020-09-04","current":-56.454938,"twenty":-69.299363,"median":-61.279481,"eighty":-56.312276,"marketCap":21447308046},{"date":"2020-09-11","current":-59.39532,"twenty":-69.034548,"median":-61.149297,"eighty":-56.381895,"marketCap":22588540951},{"date":"2020-09-18","current":-23.213534,"twenty":-68.783672,"median":-61.157004,"eighty":-56.381895,"marketCap":23847832432},{"date":"2020-09-25","current":-20.580693,"twenty":-68.608413,"median":-60.769842,"eighty":-55.354665,"marketCap":20975073740},{"date":"2020-09-30","current":-21.520592,"twenty":-68.49576,"median":-60.537717,"eighty":-54.51941,"marketCap":22037600928},{"date":"2020-10-09","current":-20.533232,"twenty":-68.261016,"median":-60.351714,"eighty":-53.10451,"marketCap":21329249469},{"date":"2020-10-16","current":-20.579561,"twenty":-67.599319,"median":-60.014098,"eighty":-50.561624,"marketCap":21368602328},{"date":"2020-10-23","current":-18.390768,"twenty":-65.566444,"median":-59.898011,"eighty":-36.752532,"marketCap":19125489376},{"date":"2020-10-30","current":-18.387929,"twenty":-65.53997,"median":-59.39532,"eighty":-22.333682,"marketCap":19125489376},{"date":"2020-11-06","current":-18.960772,"twenty":-65.539086,"median":-59.096072,"eighty":-21.714319,"marketCap":19951899411},{"date":"2020-11-13","current":-17.861227,"twenty":-65.495719,"median":-58.967855,"eighty":-21.20377,"marketCap":18810666506},{"date":"2020-11-20","current":-18.195519,"twenty":-65.439452,"median":-58.396831,"eighty":-20.827083,"marketCap":19282900812},{"date":"2020-11-27","current":-18.163703,"twenty":-65.051015,"median":-57.55027,"eighty":-20.533232,"marketCap":19204195094},{"date":"2020-12-04","current":-19.807773,"twenty":-64.515903,"median":-57.279422,"eighty":-20.022532,"marketCap":21093132316},{"date":"2020-12-11","current":-21.33702,"twenty":-64.452305,"median":-56.818854,"eighty":-20.137955,"marketCap":22667246668},{"date":"2020-12-18","current":-24.630996,"twenty":-64.186949,"median":-56.363634,"eighty":-20.421683,"marketCap":26209003960},{"date":"2020-12-24","current":-26.970119,"twenty":-63.818518,"median":-55.820181,"eighty":-20.432553,"marketCap":28727586924},{"date":"2020-12-31","current":-28.06698,"twenty":-63.629518,"median":-55.339775,"eighty":-20.494047,"marketCap":29908172688},{"date":"2021-01-08","current":-32.570823,"twenty":-63.597221,"median":-55.265323,"eighty":-20.51364,"marketCap":34984691473},{"date":"2021-01-15","current":-37.631162,"twenty":-63.40952,"median":-54.292281,"eighty":-20.570295,"marketCap":40403477353},{"date":"2021-01-22","current":-41.643907,"twenty":-63.295257,"median":-53.301351,"eighty":-20.580467,"marketCap":44693027527},{"date":"2021-01-29","current":-40.849406,"twenty":-63.217929,"median":-51.221035,"eighty":-20.705895,"marketCap":44202793221},{"date":"2021-02-05","current":-42.462881,"twenty":-63.20331,"median":-50.765107,"eighty":-20.737196,"marketCap":45673496138},{"date":"2021-02-11","current":-44.298428,"twenty":-63.199738,"median":-50.518886,"eighty":-20.809106,"marketCap":47716139078},{"date":"2021-02-19","current":-44.620302,"twenty":-63.148699,"median":-50.046102,"eighty":-20.827888,"marketCap":48083814807},{"date":"2021-02-26","current":-38.677591,"twenty":-62.923489,"median":-46.003712,"eighty":-21.003278,"marketCap":41588210258},{"date":"2021-03-05","current":-36.070462,"twenty":-62.63965,"median":-44.620302,"eighty":-21.129156,"marketCap":38687657283},{"date":"2021-03-12","current":-33.577269,"twenty":-62.438134,"median":-44.247826,"eighty":-21.158012,"marketCap":35950515744},{"date":"2021-03-19","current":-35.993074,"twenty":-62.327407,"median":-43.908841,"eighty":-21.185375,"marketCap":38524245848},{"date":"2021-03-26","current":-37.072786,"twenty":-62.202297,"median":-42.138278,"eighty":-21.221991,"marketCap":39504714459},{"date":"2021-04-01","current":-41.283195,"twenty":-62.015041,"median":-41.751169,"eighty":-21.266862,"marketCap":43875970351},{"date":"2021-04-09","current":-31.196593,"twenty":-61.70772,"median":-41.695813,"eighty":-21.319481,"marketCap":43590000339},{"date":"2021-04-16","current":-30.642009,"twenty":-61.527169,"median":-40.849406,"eighty":-21.393706,"marketCap":42977207457},{"date":"2021-04-23","current":-31.96013,"twenty":-61.441675,"median":-40.344151,"eighty":-21.433299,"marketCap":44938144680},{"date":"2021-04-30","current":-30.816187,"twenty":-61.312504,"median":-39.558199,"eighty":-21.441654,"marketCap":43508294622},{"date":"2021-05-07","current":-28.864106,"twenty":-61.27851,"median":-38.69692,"eighty":-21.489217,"marketCap":41016270235},{"date":"2021-05-14","current":-29.343194,"twenty":-61.208677,"median":-38.024901,"eighty":-21.636828,"marketCap":41669915976},{"date":"2021-05-21","current":-32.815059,"twenty":-61.158545,"median":-37.656345,"eighty":-21.839766,"marketCap":46613111890},{"date":"2021-05-28","current":-34.118192,"twenty":-61.102433,"median":-37.609185,"eighty":-22.049324,"marketCap":48941724842},{"date":"2021-06-04","current":-35.625611,"twenty":-60.979677,"median":-37.553441,"eighty":-22.116923,"marketCap":50861809206},{"date":"2021-06-10","current":-37.08623,"twenty":-60.769842,"median":-37.072786,"eighty":-22.258985,"marketCap":52986157863},{"date":"2021-06-18","current":-35.659842,"twenty":-60.584234,"median":-36.485136,"eighty":-22.270088,"marketCap":50494133476},{"date":"2021-06-25","current":-36.773665,"twenty":-60.537647,"median":-36.47778,"eighty":-22.279086,"marketCap":51923983534},{"date":"2021-06-30","current":-36.160141,"twenty":-60.48212,"median":-36.485136,"eighty":-22.301737,"marketCap":51188632076},{"date":"2021-07-09","current":-33.001535,"twenty":-60.380024,"median":-36.358401,"eighty":-22.333501,"marketCap":46572259032},{"date":"2021-07-16","current":-33.61015,"twenty":-60.247205,"median":-36.160141,"eighty":-22.684742,"marketCap":47430169066},{"date":"2021-07-23","current":-30.660269,"twenty":-60.081955,"median":-36.081197,"eighty":-23.212212,"marketCap":43263177469},{"date":"2021-07-30","current":-29.749657,"twenty":-60.025123,"median":-35.993074,"eighty":-23.780519,"marketCap":42119297422},{"date":"2021-08-06","current":-26.92917,"twenty":-59.948494,"median":-35.665203,"eighty":-24.743522,"marketCap":38034011542},{"date":"2021-08-13","current":-25.592675,"twenty":-59.918873,"median":-35.597545,"eighty":-24.965673,"marketCap":36195632896},{"date":"2021-08-20","current":-20.885732,"twenty":-59.826938,"median":-35.459665,"eighty":-24.434422,"marketCap":29454911194},{"date":"2021-08-27","current":-21.082492,"twenty":-59.613719,"median":-35.394103,"eighty":-23.176546,"marketCap":29863439782},{"date":"2021-09-03","current":-31.115126,"twenty":-59.45425,"median":-35.211108,"eighty":-23.023412,"marketCap":34806635697},{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418}],"updateTime":1743801693487}}}